FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385515016> ?p ?o ?g. }

• W4385515016 abstract "The mechanisms governing the progression of non-alcoholic fatty liver disease (NAFLD) towards steatohepatitis (NASH) and hepatocellular carcinoma (HCC) remain elusive. Here, we evaluated the role of hsa-miRNA-21-5p in NASH-related hepatocarcinogenesis.Hepatic hsa-miR-21-5p expression was evaluated in two cohorts of patients with biopsy-proven NAFLD (n = 199) or HCC (n = 366 HCC and n = 11 NAFLD-HCC). Serum/liver metabolomic profiles were correlated with hsa-miR-21-5p in NAFLD obese patients. Wild-type (WT) and Mir21 KO mice were fed a choline-deficient, amino acid-defined (CDAA) diet for 32 and 66 weeks to induce NASH and NASH-HCC, respectively.In obese individuals, hsa-miR-21-5p expression increased with NAFLD severity and associated with a hepatic lipotoxic profile. CDAA-fed WT mice displayed increased hepatic mmu-miR-21-5p levels and progressively developed NASH and fibrosis, with livers presenting macroscopically discernible pre-neoplastic nodules, hyperplastic foci and deregulated cancer-related pathways. Mir21 KO mice exhibited peroxisome-proliferator-activated receptor α (PPARα) activation, augmented mitochondrial activity, reduced liver injury and NAS below the threshold for NASH diagnosis, with the pro-inflammatory/fibrogenic milieu reversing to baseline levels. In parallel, Mir21 KO mice displayed reduced number of pre-neoplastic nodules, hepatocyte proliferation and activation of oncogenic signalling, being protected from NASH-associated carcinogenesis. The hsa-miRNA-21-5p/PPARα pathway was similarly deregulated in patients with HCC- or NASH-related HCC, correlating with HCC markers and worse prognosis.Hsa-miR-21-5p is a key inducer of whole-spectrum NAFLD progression, from simple steatosis to NASH and NASH-associated carcinogenesis. The inhibition of hsa-miR-21-5p, leading to a pro-metabolic profile, might constitute an appealing therapeutic approach to ameliorate NASH and prevent progression towards HCC." @default.
• W4385515016 created "2023-08-04" @default.
• W4385515016 creator A5002222771 @default.
• W4385515016 creator A5004169355 @default.
• W4385515016 creator A5010001054 @default.
• W4385515016 creator A5010029021 @default.
• W4385515016 creator A5013636353 @default.
• W4385515016 creator A5018012663 @default.
• W4385515016 creator A5029435804 @default.
• W4385515016 creator A5033807990 @default.
• W4385515016 creator A5042485768 @default.
• W4385515016 creator A5047251051 @default.
• W4385515016 creator A5047310284 @default.
• W4385515016 creator A5051350486 @default.
• W4385515016 creator A5061488642 @default.
• W4385515016 creator A5067308357 @default.
• W4385515016 creator A5073334388 @default.
• W4385515016 creator A5074043200 @default.
• W4385515016 creator A5079688872 @default.
• W4385515016 creator A5079769475 @default.
• W4385515016 creator A5082623940 @default.
• W4385515016 creator A5084083958 @default.
• W4385515016 date "2023-08-03" @default.
• W4385515016 modified "2023-10-18" @default.
• W4385515016 title "<scp>miR</scp>‐21‐5p promotes <scp>NASH</scp>‐related hepatocarcinogenesis" @default.
• W4385515016 cites W1668919262 @default.
• W4385515016 cites W1776128289 @default.
• W4385515016 cites W1935382102 @default.
• W4385515016 cites W2000093333 @default.
• W4385515016 cites W2017345887 @default.
• W4385515016 cites W2030063383 @default.
• W4385515016 cites W2036639432 @default.
• W4385515016 cites W2048172410 @default.
• W4385515016 cites W2065612971 @default.
• W4385515016 cites W2071030431 @default.
• W4385515016 cites W2105854609 @default.
• W4385515016 cites W2126104228 @default.
• W4385515016 cites W2126914449 @default.
• W4385515016 cites W2142319787 @default.
• W4385515016 cites W2158868597 @default.
• W4385515016 cites W2161163389 @default.
• W4385515016 cites W2174734259 @default.
• W4385515016 cites W2257770802 @default.
• W4385515016 cites W2395233788 @default.
• W4385515016 cites W2424141408 @default.
• W4385515016 cites W2508708811 @default.
• W4385515016 cites W2530466621 @default.
• W4385515016 cites W2538277817 @default.
• W4385515016 cites W2597515873 @default.
• W4385515016 cites W2605901195 @default.
• W4385515016 cites W2774439393 @default.
• W4385515016 cites W2787463271 @default.
• W4385515016 cites W2807585215 @default.
• W4385515016 cites W2884323913 @default.
• W4385515016 cites W2884907724 @default.
• W4385515016 cites W2900191558 @default.
• W4385515016 cites W2909835632 @default.
• W4385515016 cites W2929022608 @default.
• W4385515016 cites W2936054191 @default.
• W4385515016 cites W2943315701 @default.
• W4385515016 cites W2982442619 @default.
• W4385515016 cites W3009973508 @default.
• W4385515016 cites W3115479091 @default.
• W4385515016 cites W3118730333 @default.
• W4385515016 cites W3122330053 @default.
• W4385515016 cites W3128646645 @default.
• W4385515016 cites W3133228745 @default.
• W4385515016 cites W3163276782 @default.
• W4385515016 cites W3163483026 @default.
• W4385515016 cites W3202122008 @default.
• W4385515016 cites W4212806804 @default.
• W4385515016 cites W4376598120 @default.
• W4385515016 doi "https://doi.org/10.1111/liv.15682" @default.
• W4385515016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37534739" @default.
• W4385515016 hasPublicationYear "2023" @default.
• W4385515016 type Work @default.
• W4385515016 citedByCount "0" @default.
• W4385515016 crossrefType "journal-article" @default.
• W4385515016 hasAuthorship W4385515016A5002222771 @default.
• W4385515016 hasAuthorship W4385515016A5004169355 @default.
• W4385515016 hasAuthorship W4385515016A5010001054 @default.
• W4385515016 hasAuthorship W4385515016A5010029021 @default.
• W4385515016 hasAuthorship W4385515016A5013636353 @default.
• W4385515016 hasAuthorship W4385515016A5018012663 @default.
• W4385515016 hasAuthorship W4385515016A5029435804 @default.
• W4385515016 hasAuthorship W4385515016A5033807990 @default.
• W4385515016 hasAuthorship W4385515016A5042485768 @default.
• W4385515016 hasAuthorship W4385515016A5047251051 @default.
• W4385515016 hasAuthorship W4385515016A5047310284 @default.
• W4385515016 hasAuthorship W4385515016A5051350486 @default.
• W4385515016 hasAuthorship W4385515016A5061488642 @default.
• W4385515016 hasAuthorship W4385515016A5067308357 @default.
• W4385515016 hasAuthorship W4385515016A5073334388 @default.
• W4385515016 hasAuthorship W4385515016A5074043200 @default.
• W4385515016 hasAuthorship W4385515016A5079688872 @default.
• W4385515016 hasAuthorship W4385515016A5079769475 @default.
• W4385515016 hasAuthorship W4385515016A5082623940 @default.
• W4385515016 hasAuthorship W4385515016A5084083958 @default.
• W4385515016 hasBestOaLocation W43855150161 @default.
• W4385515016 hasConcept C121608353 @default.

• next